Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
Recruiting · NCT04814407 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Blood-derived DNA methylation detection
What this trial is about
The investigators aim to identify novel circulating methylated biomarkers for early lung cancer detection as well as to develop new technologies that are clinically applicable with high sensitivity and specificity.
Who can take part
Age range
20 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects suspected or confirmed diagnosis of lung cancer.
- Subjects who had indeterminate sub-centimeter pulmonary nodules or ground glass opacities discovered by computed tomography.
- Non-cancer subjects: including healthy volunteers and chronic inflammatory airway diseases such as chronic obstructive airway disease, asthma, and bronchiectasis, etc.
- Subjects age over 20.
Exclusion criteria
- Pregnancy.
- Subjects with HIV infection.
- Unable to or unwilling to give informed consent.
Where it is running
1 location listed.
- National Taiwan University Hospital - Taipei, Taiwan